209 related articles for article (PubMed ID: 38251237)
1. Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis.
Molteni F; Wissel J; Fheodoroff K; Munin MC; Patel AT; Althaus M; Comes G; Dekundy A; Pulte I; Scheschonka A; Vacchelli M; Santamato A
Toxins (Basel); 2023 Dec; 16(1):. PubMed ID: 38251237
[TBL] [Abstract][Full Text] [Related]
2. Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis.
Wissel J; Camões-Barbosa A; Comes G; Althaus M; Scheschonka A; Simpson DM
Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941725
[TBL] [Abstract][Full Text] [Related]
3. IncobotulinumtoxinA Treatment in Upper-Limb Poststroke Spasticity in the Open-Label Extension Period of PURE: Efficacy in Passive Function, Caregiver Burden, and Quality of Life.
Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP
PM R; 2020 May; 12(5):491-499. PubMed ID: 31647185
[TBL] [Abstract][Full Text] [Related]
4. Sustained efficacy of incobotulinumtoxina repeated injections for upper-limb post-stroke spasticity: A post hoc analysis.
Kaňovský P; Elovic EP; Munin MC; Hanschmann A; Pulte I; Althaus M; Hiersemenzel R; Marciniak C
J Rehabil Med; 2021 Jan; 53(1):jrm00138. PubMed ID: 33112408
[TBL] [Abstract][Full Text] [Related]
5. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.
Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP
Adv Ther; 2019 Jan; 36(1):187-199. PubMed ID: 30484117
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
Santamato A; Panza F; Intiso D; Baricich A; Picelli A; Smania N; Fortunato F; Seripa D; Fiore P; Ranieri M
J Neurol Sci; 2017 Jul; 378():182-186. PubMed ID: 28566161
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA.
Fheodoroff K; Rekand T; Medeiros L; Koßmehl P; Wissel J; Bensmail D; Scheschonka A; Flatau-Baqué B; Simon O; Dressler D; Simpson DM
Health Qual Life Outcomes; 2020 Mar; 18(1):51. PubMed ID: 32131842
[TBL] [Abstract][Full Text] [Related]
8. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE).
Masakado Y; Abo M; Kondo K; Saeki S; Saitoh E; Dekundy A; Hanschmann A; Kaji R;
J Neurol; 2020 Jul; 267(7):2029-2041. PubMed ID: 32219557
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of incobotulinumtoxinA for the treatment of adult lower-limb post-stroke spasticity, including pes equinovarus.
Bensmail D; Wissel J; Laffont I; Simon O; Scheschonka A; Flatau-Baqué B; Dressler D; Simpson DM
Ann Phys Rehabil Med; 2021 Mar; 64(2):101376. PubMed ID: 32294561
[TBL] [Abstract][Full Text] [Related]
11. IncobotulinumtoxinA: A Review in Upper Limb Spasticity.
Lamb YN; Scott LJ
Drugs; 2016 Sep; 76(14):1373-9. PubMed ID: 27530616
[TBL] [Abstract][Full Text] [Related]
12. Post hoc analysis of the improvement in shoulder spasticity and safety observed following treatment with incobotulinumtoxinA.
Wissel J; Bensmail D; Scheschonka A; Flatau-Baqué B; Simon O; Althaus M; Simpson DM
J Rehabil Med; 2020 Mar; 52(3):jrm00028. PubMed ID: 32025741
[TBL] [Abstract][Full Text] [Related]
13. Randomized, placebo-controlled trial of incobotulinumtoxina for upper-limb post-stroke spasticity.
Elovic EP; Munin MC; Kaňovský P; Hanschmann A; Hiersemenzel R; Marciniak C
Muscle Nerve; 2016 Mar; 53(3):415-21. PubMed ID: 26201835
[TBL] [Abstract][Full Text] [Related]
14. IncobotulinumtoxinA Efficacy/Safety in Upper-Limb Spasticity in Pediatric Cerebral Palsy: Randomized Controlled Trial.
Dabrowski E; Chambers HG; Gaebler-Spira D; Banach M; Kaňovský P; Dersch H; Althaus M; Geister TL; Heinen F
Pediatr Neurol; 2021 Oct; 123():10-20. PubMed ID: 34339951
[TBL] [Abstract][Full Text] [Related]
15. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
Khat'kova SE; Baikova A; Maisonobe P; Khasanova DR
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study.
Dressler D; Rychlik R; Kreimendahl F; Schnur N; Lambert-Baumann J
BMJ Open; 2015 Dec; 5(12):e009358. PubMed ID: 26719317
[TBL] [Abstract][Full Text] [Related]
17. Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201.
Fiore P; Santamato A; Ranieri M; Bellomo RG; Saggini R; Panza F; Megna G; Cristella G; Megna M
Int J Immunopathol Pharmacol; 2012; 25(1 Suppl):57S-62S. PubMed ID: 22652163
[TBL] [Abstract][Full Text] [Related]
18. Spasticity-related pain in children/adolescents with cerebral palsy. Part 2: IncobotulinumtoxinA efficacy results from a pooled analysis.
Bonfert M; Heinen F; Kaňovský P; Schroeder AS; Chambers HG; Dabrowski E; Geister TL; Hanschmann A; Althaus M; Banach M; Gaebler-Spira D
J Pediatr Rehabil Med; 2023; 16(1):83-98. PubMed ID: 36057802
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A in post-stroke upper limb spasticity.
Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
Curr Med Res Opin; 2010 Aug; 26(8):1983-92. PubMed ID: 20569068
[TBL] [Abstract][Full Text] [Related]
20. Does botulinum toxin treatment improve upper limb active function?
Levy J; Molteni F; Cannaviello G; Lansaman T; Roche N; Bensmail D
Ann Phys Rehabil Med; 2019 Jul; 62(4):234-240. PubMed ID: 29960017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
